Celularity to provide research support for Regeneron's targeted, allogeneic, chimeric antigen receptor (CAR) T-cell therapy
Agreement underscores Celularity's demonstrated expertise in cell therapy
Jack Dorsey’s fintech company Block Inc (NYSE: SQ) is responding to a Thursday short report issued by Hindenburg Research that accuses Block of misleading investors and taking advantage of the people it claims to help.